Abstract
Ixazomib, Thalidomide and Dexamethasone (IxaThalDex) in Relapsed/Refractory Multiple Myeloma (RRMM): An Interim Analysis of a Phase II Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have